Celanese Corporation
Celanese Corporation, a chemical and specialty materials company, manufactures and sells engineered polymers worldwide. The Engineered Materials segment offers nylon and polypropylene compounds and formulations, high temperature nylon, polyoxymethylene, polyethylene and polybutylene terephthalates, ultra-high molecular weight polyethylene, long-chain polyamides, long-fiber reinforced thermoplasti… Read more
Celanese Corporation (CE) - Net Assets
Latest net assets as of September 2025: $4.38 Billion USD
Based on the latest financial reports, Celanese Corporation (CE) has net assets worth $4.38 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($22.17 Billion) and total liabilities ($17.79 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.38 Billion |
| % of Total Assets | 19.75% |
| Annual Growth Rate | 4.69% |
| 5-Year Change | 44.01% |
| 10-Year Change | 98.27% |
| Growth Volatility | 65.68 |
Celanese Corporation - Net Assets Trend (2001–2024)
This chart illustrates how Celanese Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Celanese Corporation (2001–2024)
The table below shows the annual net assets of Celanese Corporation from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $5.61 Billion | -25.73% |
| 2023-12-31 | $7.55 Billion | +23.70% |
| 2022-12-31 | $6.11 Billion | +34.56% |
| 2021-12-31 | $4.54 Billion | +16.48% |
| 2020-12-31 | $3.90 Billion | +34.40% |
| 2019-12-31 | $2.90 Billion | -14.23% |
| 2018-12-31 | $3.38 Billion | +2.42% |
| 2017-12-31 | $3.30 Billion | +9.20% |
| 2016-12-31 | $3.02 Billion | +6.79% |
| 2015-12-31 | $2.83 Billion | -8.09% |
| 2014-12-31 | $3.08 Billion | +14.04% |
| 2013-12-31 | $2.70 Billion | +56.01% |
| 2012-12-31 | $1.73 Billion | +29.01% |
| 2011-12-31 | $1.34 Billion | +45.13% |
| 2010-12-31 | $924.00 Million | +58.22% |
| 2009-12-31 | $584.00 Million | +217.39% |
| 2008-12-31 | $184.00 Million | -82.76% |
| 2007-12-31 | $1.07 Billion | +23.93% |
| 2006-12-31 | $861.00 Million | +187.96% |
| 2005-12-31 | $299.00 Million | -26.35% |
| 2004-12-31 | $406.00 Million | -84.38% |
| 2003-12-31 | $2.60 Billion | +24.05% |
| 2002-12-31 | $2.10 Billion | +7.27% |
| 2001-12-31 | $1.95 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Celanese Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1110000000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $11.10 Billion | 214.49% |
| Common Stock | $17.08K | 0.00% |
| Other Comprehensive Income | $-848.00 Million | -16.39% |
| Total Equity | $5.17 Billion | 100.00% |
Celanese Corporation Competitors by Market Cap
The table below lists competitors of Celanese Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LIG Nex1 Co Ltd
KO:079550
|
$6.45 Billion |
|
Sanmina Corporation
NASDAQ:SANM
|
$6.45 Billion |
|
Paramount Global
SA:C1BS34
|
$6.47 Billion |
|
Dutch Bros Inc
NYSE:BROS
|
$6.47 Billion |
|
ICON Public Limited Company
F:IJF
|
$6.43 Billion |
|
BERKSHIRE HATH-A
BE:BRH
|
$6.43 Billion |
|
VF Corporation
NYSE:VFC
|
$6.43 Billion |
|
Mytilineos S.A
PINK:MYTHF
|
$6.43 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Celanese Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,091,000,000 to 5,175,000,000, a change of -1,916,000,000 (-27.0%).
- Net loss of 1,522,000,000 reduced equity.
- Dividend payments of 307,000,000 reduced retained earnings.
- Share repurchases of 1,000,000 reduced equity.
- Other comprehensive income decreased equity by 104,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.52 Billion | -29.41% |
| Dividends Paid | $307.00 Million | -5.93% |
| Share Repurchases | $1.00 Million | -0.02% |
| Other Comprehensive Income | $-104.00 Million | -2.01% |
| Other Changes | $18.00 Million | +0.35% |
| Total Change | $- | -27.02% |
Book Value vs Market Value Analysis
This analysis compares Celanese Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.27x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.55x to 1.27x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $38.82 | $60.18 | x |
| 2002-12-31 | $30.44 | $60.18 | x |
| 2003-12-31 | $44.84 | $60.18 | x |
| 2004-12-31 | $-1.29 | $60.18 | x |
| 2005-12-31 | $1.41 | $60.18 | x |
| 2006-12-31 | $4.58 | $60.18 | x |
| 2007-12-31 | $6.20 | $60.18 | x |
| 2008-12-31 | $1.11 | $60.18 | x |
| 2009-12-31 | $3.72 | $60.18 | x |
| 2010-12-31 | $5.83 | $60.18 | x |
| 2011-12-31 | $8.44 | $60.18 | x |
| 2012-12-31 | $10.83 | $60.18 | x |
| 2013-12-31 | $16.94 | $60.18 | x |
| 2014-12-31 | $18.04 | $60.18 | x |
| 2015-12-31 | $15.62 | $60.18 | x |
| 2016-12-31 | $17.77 | $60.18 | x |
| 2017-12-31 | $20.87 | $60.18 | x |
| 2018-12-31 | $22.04 | $60.18 | x |
| 2019-12-31 | $20.11 | $60.18 | x |
| 2020-12-31 | $29.76 | $60.18 | x |
| 2021-12-31 | $37.37 | $60.18 | x |
| 2022-12-31 | $51.60 | $60.18 | x |
| 2023-12-31 | $64.83 | $60.18 | x |
| 2024-12-31 | $47.36 | $60.18 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Celanese Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -29.41%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -14.81%
- • Asset Turnover: 0.45x
- • Equity Multiplier: 4.42x
- Recent ROE (-29.41%) is below the historical average (37.97%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | -18.68% | -9.51% | 0.62x | 3.19x | $-560.40 Million |
| 2002 | 8.02% | 4.54% | 0.58x | 3.06x | $-41.60 Million |
| 2003 | 5.73% | 3.22% | 0.68x | 2.64x | $-110.20 Million |
| 2004 | 0.00% | -6.61% | 0.52x | 0.00x | $-241.80 Million |
| 2005 | 117.87% | 4.56% | 0.82x | 31.68x | $253.50 Million |
| 2006 | 51.59% | 6.10% | 0.84x | 10.03x | $327.30 Million |
| 2007 | 40.11% | 6.61% | 0.80x | 7.59x | $319.80 Million |
| 2008 | 154.95% | 4.13% | 0.95x | 39.37x | $263.80 Million |
| 2009 | 83.56% | 9.60% | 0.60x | 14.40x | $429.60 Million |
| 2010 | 40.58% | 6.34% | 0.71x | 8.96x | $282.60 Million |
| 2011 | 45.26% | 8.98% | 0.79x | 6.35x | $472.90 Million |
| 2012 | 34.97% | 9.43% | 0.70x | 5.29x | $432.00 Million |
| 2013 | 40.79% | 16.91% | 0.72x | 3.34x | $831.10 Million |
| 2014 | 22.14% | 9.17% | 0.77x | 3.13x | $342.20 Million |
| 2015 | 12.78% | 5.36% | 0.66x | 3.61x | $66.20 Million |
| 2016 | 34.78% | 16.70% | 0.64x | 3.23x | $641.20 Million |
| 2017 | 29.20% | 13.73% | 0.64x | 3.30x | $554.30 Million |
| 2018 | 40.45% | 16.87% | 0.77x | 3.12x | $908.60 Million |
| 2019 | 33.98% | 13.53% | 0.66x | 3.78x | $601.30 Million |
| 2020 | 56.30% | 35.10% | 0.52x | 3.09x | $1.63 Billion |
| 2021 | 45.12% | 22.14% | 0.71x | 2.86x | $1.47 Billion |
| 2022 | 33.60% | 19.58% | 0.37x | 4.66x | $1.33 Billion |
| 2023 | 27.64% | 17.92% | 0.41x | 3.75x | $1.25 Billion |
| 2024 | -29.41% | -14.81% | 0.45x | 4.42x | $-2.04 Billion |
Industry Comparison
This section compares Celanese Corporation's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $4,743,108,505
- Average return on equity (ROE) among peers: -0.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Celanese Corporation (CE) | $4.38 Billion | -18.68% | 4.06x | $6.44 Billion |
| Synalloy Corporation (ACNT) | $26.00 Million | 24.62% | 0.65x | $96.97 Million |
| Advance ZincTek Limited (ADVNF) | $34.99 Million | 6.26% | 0.09x | $5.02 Million |
| AdvanSix Inc (ASIX) | $215.36 Million | 15.86% | 3.20x | $435.20 Million |
| ASP Isotopes Inc. Common Stock (ASPI) | $6.00 Million | -43.48% | 0.19x | $437.78 Million |
| Braskem SA Class A (BAK) | $5.89 Billion | 14.66% | 7.38x | $970.61 Million |
| Bachem Holding AG (BCHMF) | $389.21 Million | 11.99% | 0.14x | $1.98 Billion |
| BASF SE NA O.N. (BFFAF) | $36.11 Billion | 13.04% | 1.40x | $47.09 Billion |
| BioLargo Inc (BLGO) | $-770.20K | 0.00% | 0.00x | $51.87 Million |
| Black Swan Graphene Inc. (BSWGF) | $13.83 Million | -43.99% | 0.01x | $10.07 Million |